P. Clausen et al., MICROALBUMINURIA AS AN EARLY INDICATOR OF OSTEOPENIA IN MALE INSULIN-DEPENDENT DIABETIC-PATIENTS, Diabetic medicine, 14(12), 1997, pp. 1038-1043
Reduced bone mineral density (BMD), termed diabetic osteopenia, has be
en reported in patients with insulin-dependent (Type 1) diabetes melli
tus (IDDM). To examine BMD in long-term IDDM patients with normal kidn
ey function, but with different degrees of urinary albumin excretion r
ate (UAER), compared to that of patients with elevated plasma creatini
ne, 36 IDDM male patients (mean duration 27 years) were subdivided acc
ording to UAER (<30, 30-300, >300, >300 mg 24 h(-1) and plasma creatin
ine 0.120-0.350 mmol l(-1)) and 15 controls were recruited. BMD was me
asured by dual energy X-ray absorptiometry and UAER by enzyme linked i
mmunosorbent assay. BMD was normal in IDDM patients with normal UAER a
nd reduced in the femoral neck, the trochanter major, and the Wards tr
iangle in patients with increased UAER (p < 0.01, p < 0.05, p<0.02). B
MD correlated to creatinine clearance in both cortical and cancellous
bone sites (p < 0.001, p < 0.0001), and inversely to the levels of pla
sma PTH (p < 0.0005). We conclude that BMD is normal in long-term IDDM
male patients with normal kidney function and normal UAER and reduced
in patients with increased UAER. Diabetic osteopenia seems to be a pr
ogressive phenomenon related to diabetic nephropathy and associated wi
th the decrease in creatinine clearance and with the resulting rise in
plasma PTH. (C) 1997 by John Wiley & Sons, Ltd.